[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100455378":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":34,"locations":43,"responsibleParty":65,"collaborators":25,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":69,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":25,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":46,"whyStopped":25,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"University Hospital, Toulouse","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients","EXPERIMENTAL","Carrier of a definite diagnosis of arrhythmogenic dysplasia of the right ventricle in line with the criteria of the Task Force 2010 (see Appendices), admitted for an electrical mapping of the right ventricle",[13,14],"Biological: Peripheral immunological assessment on venous blood","Biological: Immunological assessment carried out on intracardiac material",{"label":16,"type":10,"description":17,"interventionNames":18},"Control case","Without heart disease, admitted for a Kent bundle ablation or endocavity procedure \u002F Wolff-Parkinson-White syndrome or common flutter (in subjects in whom the same irrigated material will be used and for whom echocardiography will have excluded associated heart disease).",[13,14],[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"BIOLOGICAL","Peripheral immunological assessment on venous blood","Peripheral immunological assessment carried out as part of the research, on venous blood at the puncture point necessary for the electrophysiological examination: 1 heparin tube and 1 EDTA tube",[16,9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Immunological assessment carried out on intracardiac material","Immunological assessment carried out as part of the research, on intracardiac material taken during the electrophysiological examination: 1 EDTA tube",[16,9],[31],{"name":32,"affiliation":5,"role":33},"Philippe MAURY, MD","PRINCIPAL_INVESTIGATOR",[35,40],{"name":32,"role":36,"phone":37,"phoneExt":38,"email":39},"CONTACT","5 61 32 34 70","+33","maury.p@chu-toulouse.fr",{"name":41,"role":36,"phone":25,"phoneExt":25,"email":42},"Maxime BENEYTO","beneyto.m@chu-toulouse.fr",[44],{"facility":45,"status":46,"city":47,"state":25,"zip":25,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Toulouse University Hospital Center","RECRUITING","Toulouse","France","FR",{"type":51,"coordinates":52},"Point",[53,54],1.44367,43.60426,{"lat":54,"lon":53},[57,61,63],{"name":58,"role":36,"phone":59,"phoneExt":38,"email":60},"Audrey TOMASIK","5 61 77 85 97","tomasik.a@chu-toulouse.fr",{"name":62,"role":33,"phone":25,"phoneExt":25,"email":25},"Philippe MAURY",{"name":41,"role":64,"phone":25,"phoneExt":25,"email":25},"SUB_INVESTIGATOR",{"type":66,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100455378","local-inflammation-in-arrhythmogenic-right-ventricular-cardiomyopathy-100455378",false,"NCT05209776","Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy","LI-ARVC","Inclusion Criteria:\n\n* For cases:\n\n  * Arrhythmogenic right ventricular dysplasia diagnosed (according to 2010 Task Force Criteria)\n  * Admitted for right ventricle electrophysiologic mapping\n* For controls \\* Admitted for ablation procedures (accessory pathway, atrial flutter) on otherwise healthy hearts.\n\nExclusion Criteria:\n\n* Diagnostic of systemic chronic inflammatory disease\n* Presence of possible or proven cardiac involvement of an inflammatory disease, an acute or chronic infectious disease.\n* Taking immunosuppressant or immunomodulating medications","ALL","18 Years","99 Years",{"count":78,"type":79},80,"ESTIMATED","INTERVENTIONAL",[82],"NA","The understanding of ARVC pathophysiology remains incomplete. Several clues indicate that disease progression is mediated through inflammation. The present study aim to document the feasibility of detecting the potential presence of intracardiac local inflammatory components in patients with ARVC.",[85],"Arrhythmogenic Right Ventricular Dysplasia",[87,88,89,90,91,92,93,94],"Cardiac Electrophysiologic Techniques","Inflammation","Cytokines","Interleukin-1","Interleukin-6","Interleukin-10","Transforming Growth Factor beta","Tumor Necrosis Factor-alpha","2026-05-28",{"date":97,"type":98},"2026-06-01","ACTUAL",{"date":100,"type":98},"2022-02-01",{"date":102,"type":79},"2027-02",{"name":5,"class":6},1]